SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Francisco A. Ponce, Advances in Deep Brain Stimulation for Parkinson Disease: Early and “Asleep”?, World Neurosurgery, 2014, 81, 1, 6

    CrossRef

  2. 2
    Kevin T. Stroupe, Frances M. Weaver, Lishan Cao, Dolores Ippolito, Brandon R. Barton, Inger E. Burnett-Zeigler, Robert G. Holloway, Barbara G. Vickrey, Tanya Simuni, Kenneth A. Follett, Cost of deep brain stimulation for the treatment of Parkinson's disease by surgical stimulation sites, Movement Disorders, 2014, 29, 13
  3. 3
    X.L. Zhu, Danny T.M. Chan, Claire K.Y. Lau, Wai S. Poon, Vincent C.T. Mok, Anne Y.Y. Chan, Lawrence K.S. Wong, Jonas H.M. Yeung, Michael C.M. Leung, Venus Y.H. Tang, Rosanna K.M. Wong, Carol Yeung, Cost-Effectiveness of Subthalmic Nucleus Deep Brain Stimulation for the Treatment of Advanced Parkinson Disease in Hong Kong: A Prospective Study, World Neurosurgery, 2014, 82, 6, 987

    CrossRef

  4. 4
    Laura Y. Cabrera, Emily L. Evans, Roy H. Hamilton, Ethics of the Electrified Mind: Defining Issues and Perspectives on the Principled Use of Brain Stimulation in Medical Research and Clinical Care, Brain Topography, 2014, 27, 1, 33

    CrossRef

  5. 5
    Christofer Lundqvist, Antonie Giæver Beiske, Ola Reiertsen, Ivar Sønbø Kristiansen, Real life cost and quality of life associated with continuous intraduodenal levodopa infusion compared with oral treatment in Parkinson patients, Journal of Neurology, 2014, 261, 12, 2438

    CrossRef

  6. 6
    Tiago A. Mestre, Alberto J. Espay, Connie Marras, Mark H. Eckman, Pierre Pollak, Anthony E. Lang, Subthalamic nucleus-deep brain stimulation for early motor complications in Parkinson's disease—the EARLYSTIM trial: Early is not always better, Movement Disorders, 2014, 29, 14
  7. 7
    Simon Eggington, Francesc Valldeoriola, K. Ray Chaudhuri, Keyoumars Ashkan, Elena Annoni, Günther Deuschl, The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson’s disease, Journal of Neurology, 2014, 261, 1, 106

    CrossRef

  8. 8
    E. Ray Dorsey, Allison W. Willis, Caring for the majority, Movement Disorders, 2013, 28, 3
  9. 9
    Francesc Valldeoriola, Jaume Puig-Junoy, Ruth Puig-Peiró, Cost analysis of the treatments for patients with advanced Parkinson's disease: SCOPE study, Journal of Medical Economics, 2013, 16, 2, 191

    CrossRef

  10. 10
    Judith Dams, Uwe Siebert, Bernhard Bornschein, Jens Volkmann, Günther Deuschl, Wolfgang H. Oertel, Richard Dodel, Jens-Peter Reese, Cost-effectiveness of deep brain stimulation in patients with Parkinson's disease, Movement Disorders, 2013, 28, 6
  11. 11
    Megan K. Young, Shu-Kay Ng, George Mellick, Paul A. Scuffham, Mapping of the PDQ-39 to EQ-5D scores in patients with Parkinson’s disease, Quality of Life Research, 2013, 22, 5, 1065

    CrossRef

  12. 12
    Michael R. Gionfriddo, Alexandra J. Greenberg, Abhijeet L. Wahegaonkar, Kendall H. Lee, Pathways of Translation: Deep Brain Stimulation, Clinical and Translational Science, 2013, 6, 6
  13. 13
    Jens Volkmann, Alberto Albanese, Angelo Antonini, K. Ray Chaudhuri, Carl E. Clarke, Rob M. A. Bie, Günther Deuschl, Karla Eggert, Jean-Luc Houeto, Jaime Kulisevsky, Dag Nyholm, Per Odin, Karen Østergaard, Werner Poewe, Pierre Pollak, Jose Martin Rabey, Olivier Rascol, Evzen Ruzicka, Michael Samuel, Hans Speelman, Olof Sydow, Francesc Valldeoriola, Chris Linden, Wolfgang Oertel, Selecting deep brain stimulation or infusion therapies in advanced Parkinson’s disease: an evidence-based review, Journal of Neurology, 2013, 260, 11, 2701

    CrossRef

  14. 14
    Huan-guang Liu, Yu Ma, Kai Zhang, Ming Ge, Fan-gang Meng, Tao Feng, Xin-hua Wan, Yi Guo, Ren-zhi Wang, An-chao Yang, Wen-han Hu, Jin-zu Guo, Jian-guo Zhang, Subthalamic Deep Brain Stimulation With a New Device in Parkinson's Disease: An Open-Label Trial, Neuromodulation: Technology at the Neural Interface, 2013, 16, 3
  15. 15
    P. F. Worth, When the going gets tough: how to select patients with Parkinson's disease for advanced therapies, Practical Neurology, 2013, 13, 3, 140

    CrossRef

  16. 16
    Emily Bell, Eric Racine, Brain Stimulation, 2013,

    CrossRef

  17. 17
    Francesc Valldeoriola, Josep Valls-Sole, Cycling thalamic stimulation, neuronal entropy, and tremor, Clinical Neurophysiology, 2012, 123, 5, 856

    CrossRef

  18. 18
    Frances M. Weaver, Kevin T. Stroupe, Lishan Cao, Robert G. Holloway, Barbara G. Vickrey, Tanya Simuni, Ann Hendricks, Dolores Ippolito, Parkinson's disease medication use and costs following deep brain stimulation, Movement Disorders, 2012, 27, 11
  19. 19
    Jens P Reese, Judith Dams, Yaroslav Winter, Monika Balzer-Geldsetzer, Wolfgang H Oertel, Richard Dodel, Pharmacoeconomic considerations of treating patients with advanced Parkinson's disease, Expert Opinion on Pharmacotherapy, 2012, 13, 7, 939

    CrossRef

  20. 20
    Julia Lowin, Annika Bergman, K. Ray Chaudhuri, Leslie J. Findley, Claudia Roeder, Mathias Schifflers, Eifiona Wood, Stephen Morris, A cost-effectiveness analysis of levodopa/carbidopa intestinal gel compared to standard care in late stage Parkinson’s disease in the UK, Journal of Medical Economics, 2011, 14, 5, 584

    CrossRef

  21. 21
    Poul Jennum, Marielle Zoetmulder, Lise Korbo, Jakob Kjellberg, The health-related, social, and economic consequences of parkinsonism: a controlled national study, Journal of Neurology, 2011, 258, 8, 1497

    CrossRef

  22. 22
    Jared M. Pisapia, Casey H. Halpern, Noel N. Williams, Thomas A. Wadden, Gordon H. Baltuch, Sherman C. Stein, Deep brain stimulation compared with bariatric surgery for the treatment of morbid obesity: a decision analysis study, Neurosurgical FOCUS, 2010, 29, 2, E15

    CrossRef

  23. 23
    Alberto J. Espay, Jennifer E. Vaughan, Connie Marras, Rob Fowler, Mark H. Eckman, Early versus delayed bilateral subthalamic deep brain stimulation for parkinson's disease: A decision analysis, Movement Disorders, 2010, 25, 10
  24. 24
    Vanessa K. Hinson, Parkinson’s Disease and Motor Fluctuations, Current Treatment Options in Neurology, 2010, 12, 3, 186

    CrossRef

  25. 25
    Shin-Yuan Chen, Sheng-Tzung Tsai, The Epidemiology of Parkinson's Disease, Tzu Chi Medical Journal, 2010, 22, 2, 73

    CrossRef

  26. 26
    Emily Bell, Ghislaine Mathieu, Eric Racine, Preparing the ethical future of deep brain stimulation, Surgical Neurology, 2009, 72, 6, 577

    CrossRef

  27. 27
    Ivar Sønbø Kristiansen, Kerstin Bingefors, Dag Nyholm, Dag Isacson, Short-term cost and health consequences of duodenal levodopa infusion in advanced Parkinson’s disease in Sweden, Applied Health Economics and Health Policy, 2009, 7, 3, 167

    CrossRef

  28. 28
    Carl E. Clarke, Paul Worth, Donald Grosset, David Stewart, Systematic review of apomorphine infusion, levodopa infusion and deep brain stimulation in advanced Parkinson's disease, Parkinsonism & Related Disorders, 2009, 15, 10, 728

    CrossRef

  29. 29
    Patricia Limousin, Irene Martinez-Torres, Deep brain stimulation for Parkinson’s disease, Neurotherapeutics, 2008, 5, 2, 309

    CrossRef